Company Q1 Investor Calls: Most IVD companies have downplayed tariff impact. Small % of revenues affected. Most emphasizing the industry’s having the most advanced supply chains in global industry, one that can shift as tariff targets change.
2 Major Trade Associations: Tariffs are damaging and we need a medical exemption.
IVD Industry Blogger: Some of this “confidence” about low tariff impact on 2025 is that respiratory revenues have been earned pre-tariffs.
IVD Blogger: Watch statements – some are made when the China tariffs were not yet in place or not yet delayed. The only consistency has been uncertainty.
IVD Market Research Firm: The USA accounts for over 40% of IVD dollar value consumption in the world. USA based tariff actions have a significant effect on the global industry. Tariffs on importing IVD related goods, e.g. into the USA by 10%.
IVD Market Research Firm: China identified goods will be subject to unique tariffs its counter tariffs will increase prices in the USA not only for consumer goods but also for goods produced in the USA using inputs, parts and reagents, from China.
IVD Market Research Firm: We are lowering our IVD total revenue outlook for 2026 and beyond as tariffs are expected to reduce economic growth.
For these changin developments – you need a resource that keeps tracking the IVD market, one from objective sources! One that adjusts as there are changes. We have them.
